Probiotics in the Treatment of Irritable Bowel Syndrome
NCT ID: NCT01837485
Last Updated: 2013-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
82 participants
INTERVENTIONAL
2011-08-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Probiotics in the Treatment of Irritable Bowel Syndrome
NCT01837472
Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome
NCT01886781
The Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome
NCT05064930
Probiotics for Irritable Bowel Syndrome
NCT00355810
Probiotics as Adjuvant Therapy in the Management of Irritable Bowel Syndrome
NCT05523427
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lactol
Lactol
The Symbiotic Lactol® (Bioplus Life Sciences Pvt.) was applied 3 times a day for 3 months. Lactol is composed of the followings; Lactobacillus Sporogenes (15 × 107 Spores), Fructo-Oligosaccharides, Microcrystalline Cellulose, Sodium starch Glycolate, Povidone, Hypermellose Stearate, Sillicon Dioxide, and Propylene Glycol.
Placebo
Placebo
Placebo pill was applied 3 times a day for 3 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lactol
The Symbiotic Lactol® (Bioplus Life Sciences Pvt.) was applied 3 times a day for 3 months. Lactol is composed of the followings; Lactobacillus Sporogenes (15 × 107 Spores), Fructo-Oligosaccharides, Microcrystalline Cellulose, Sodium starch Glycolate, Povidone, Hypermellose Stearate, Sillicon Dioxide, and Propylene Glycol.
Placebo
Placebo pill was applied 3 times a day for 3 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of IBS based on the Rome III criteria
* willingness to participate
Exclusion Criteria
* receiving antibiotics during the study
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Islamic Azad University, Najafabad Branch
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mozhdeh Zahiri
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mozhdeh Zahiri, MD
Role: PRINCIPAL_INVESTIGATOR
Islamic Azad University, Najafabad Branch
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shariati Hospital
Isfahan, Isfahan, Iran
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15010101882058
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.